Prostate-specific antigen or human kallikrein 3? Recent developments

Tumor Biology

Volumn 19, Issue 2, 1998, Pages 65-68

  Diamandis, Eleftherios P ^a  

^a MOUNT SINAI HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

KALLIKREIN; PROSTATE SPECIFIC ANTIGEN; TUMOR MARKER;

ADENOCARCINOMA; BIOSYNTHESIS; BLOOD; BREAST DISEASE; BREAST TUMOR; CELL CULTURE; FEMALE; HUMAN; MALE; MASS SCREENING; METABOLISM; NOMENCLATURE; NOTE; PREDICTION AND FORECASTING; PROSTATE TUMOR;

ADENOCARCINOMA; BREAST DISEASES; BREAST NEOPLASMS; FEMALE; HUMANS; KALLIKREINS; MALE; MASS SCREENING; PREDICTIVE VALUE OF TESTS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; TERMINOLOGY; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 0031612757     PISSN: 10104283     EISSN: None     Source Type: Journal    
DOI: 10.1159/000029976     Document Type: Article

References (43)

1. References 1 Chu TM: Prostate-specific antigen and early detection of prostate cancer. Tumor Biol 1997;18:123-134.
2. McCormack RT, Rittenhouse HG, Finlay JA, et al: Molecular forms of prostate-specific antigen and the human kallikrein gene family: A new era. Urology 1995;45:729-744.
3. Diamandis EP, Yu H: New biological functions of prostate specific antigen? J Clin Endocrinol Metab 1995;80:1515-1517.
4. Diamandis EP: Prostate specific antigen - New applications in breast and other cancers. Anticancer Res 1996;16:3983-3986.
5. Diamandis EP: New diagnostic applications of prostate specific antigen. Br J Urol 1997;79(suppl):8791.
6. Diamandis EP,YuH:Non-prostatic sources of prostate-specific antigen; in Oesterling JE (ed): The Urologie Clinics of North America: ProstateSpecific Antigen: The Best Prostatic Tumor Marker. Philadelphia. Saunders, 1997, vol 24, pp 275-282.
7. Graves HCB: Non-prostatic sources of prostate-specific antigen: A steroid hormone-dependent phenomenon? Clin Chem 1995;41:7-9.
8. Diamandis EP, Yu H, Sutherland DJA: Detection of prostate specific antigen immunoreactivity in breast tumors. Breast Cancer Res Treat 1994;32:30I-310.
9. Yu H, Diamandis EP, Sutherland DJA: Immunoreactive prostate specific antigen levels in female and male breast tumors and its association with steroid hormone receptors and patient age. Clin Biochem 1994; 27:75-79.
10. Yu H, Diamandis EP, Levesque MA, Sismondi P, Zola P, Katsaros D: Ectopic production of prostate specific antigen by a breast tumor metastatic to the ovary. J Clin Lab Anal 1994;8:251-253.
11. Monne M, Croce CM, Yu H, Diamandis EP: Molecular characterization of prostate specific antigen mRNA expressed in breast tumors. Cancer Res 1994;54:6344-6347.
12. Yu H, Diamandis EP, Monne M, Croce CM: Oral contraceptive-induced expression of prostate specific antigen in the female breast. J Biol Chem 1995;270:6615-6618.
13. Zarghami N, Diamandis EP: Detection of prostate specific antigen mRNA and protein in breast tumors. Clin Chem I996;42:361-366.
14. Yu H, Diamandis EP, Levesque M, Giai M, Roagna R, Ponzone R, Sismondi P, Monne M, Croce C: Prostatic specific antigen in breast cancer, benign breast disease and normal breast tissue. Breast Cancer Res Treat 1996;40:171-178.
15. Howarth DJC, Aronson IB, Diamandis EP: Immunohistochemical localization of prostate specific antigen in benign and malignant breast tissues. Br J Cancer 1997;75:16461651.
16. Yu H, Diamandis EP, Zarghami N, Grass L: Induction of prostate specific antigen production by steroids and tamoxifen in breast cancer cell lines. Breast Cancer Res Treat 1994; 32:291-300.
17. Zarghami N, Grass L, Diamandis EP: Steroid hormone regulation of prostate specific antigen gene expression in breast cancer. Br J Cancer 1997;75:578-588.
18. Yu H, Diamandis EP: Prostatic specific antigen in milk of lactating women. Clin Chem 1995;41:54-58.
19. Diamandis EP, Yu H, Lopez-Otin C: Prostatic specific antigen - A new constituent of breast cyst fluid. Breast Cancer Res Treat 1996;38: 259-264.
20. Mannello F, Bocchiotti G, Bianchi G, Marcheggiani F, Gazzanelli G: Quantification of prostate-specific antigen immunoreactivity in human breast cyst fluids. Breast Cancer Res Treat 1996;38:247-252.
21. Yu H, Diamandis EP: Prostate specific antigen immunoreactivity in amniotic fluid. Clin Chem 1995;41: 204-210.
22. Melegos DM, Yu H, Allen LC, Diamandis EP: Prostate specific antigen in amniotic fluid of normal and abnormal pregnancies. Clin Chem 1996;29:555-562.
23. Lambert-Messerlian GM, Canick JA, Melegos DN, Diamandis EP: Prostate specific antigen levels are relevated in 'maternal serum from pregnancies affected with fetal Down syndrome. Clin Chem (in press).
24. Levesque M, Yu H, D'Costa M, Diamandis EP: Prostate specific antigen expression by various tumors. J Clin Lab Anal 1995;9:123-128.
25. James GK, Pudck M, Berean DW, Diamandis EP, Archibald BL: Salivary duct carcinoma secreting prostate specific antigen. Am J Clin Pathol 1996;106:242-247.
26. van Krieken JHJM: Prostate marker immunorcactivity in salivary gland neoplasms. Am J Surg Pathol 1993; 17:410-414.
27. Yu H, Diamandis EP: Measurement of serum prostate specific antigen levels in females and in prostatectomized males with an ultrasensitive immunoassay technique. J Urol 1995;153:1004-1008.
28. Giai M, Yu H, Roagna R, Ponzone R, Katsaros D, Levesque MA, Diamandis EP: Prostate specific antigen in serum of women with breast cancer. Br J Cancer 1995;72:728-731.
29. Melegos D, Diamandis EP: Diagnostic value of molecular forms of prostate specific antigen for female breast cancer. Clin Biochem 1996; 29:193-200.
30. Bordiert GH, Melegos DN.Tomlinson G, Giai M, Roagna R, Ponzone R, Sgro L, Diamandis EP: Molecular forms of prostate specific antigen in the serum of women with benign and malignant breast diseases. Br J Cancer 1997;76:1087-1094.
31. Zarghami N, Grass L, Sauter ER, Diamandis EP: Prostate specific antigen levels in serum during the menstrual cycle. Clin Chem 1997; 43:1862-1867.
32. Mannello F, Bianchi G, Gazzanelli G: Immunoreactivity of prostatespecific antigen in plasma and saliva of healthy women. Clin Chem 1996; 42:1110-1111.
33. Filella X, Molina R, Alcover J, Carretero P, Ballesta AM: Detection of nonprostatic PSA in serum and nonserum samples from women. Int J Cancer 1996;68:424-427.
34. Yu H, Giai M, Diamandis EP, Katsaros D, Sutherland DJA, Levesque MA, Roagna R, Ponzone R, Sismondi P: Prostatic specific antigen is a new favourable prognostic indicator for women with breast cancer. Cancer Res 1995;55:2104-2110.
35. Yu H, Diamandis EP, Levesque M, Asa S, Monne M, Croce CM: Expression of the prostate-specific antigen gene by a primary ovarian carcinoma. Cancer Res 1995;55:16031606.
36. Levesque M, Yu H, D'Costa M, Tadross L, Diamandis EP: Immunoreactive prostate specific antigen in lung tumors. J Clin Lab Anal 1995; 9:375-379.
37. Zarghami N, Levesque M, D'Costa M, Angclopoulou K, Diamandis EP: Frequency of expression of prostate specific antigen mRNA in lung tumors. Ara J Clin Pathol 1997; 108: 184-190.
38. Zarghami N, D'Costa M, Tsuyuki D, Asa SL, Diamandis EP: Expression of the prostate specific antigen gene by lung tissue. Clin Cancer Res 1997;3:1201-1206.
39. Diamandis EP, Yu H: Prostate-specific antigen and lack of specificity for prostate cells. Lancet 1995;345: 1186.
40. Sauter ER, Daly M, Lenahan K, Ehya H, Engstrom PF, Sorling A, Bonney G, Yu H, Diamandis EP: Prostate specific antigen levels in nipple aspirate fluid correlate with breast cancer risk. Cancer Epidemiol Biomarkers Prev 1996;5:967970.
41. Foretova L, Garber JE, Sadowsky NL, Verselis S3, Li FP: Prostate-specific antigen in nipple aspirate. Lancet 1996;347:1631.
42. Melegos D, Yu H, Ashok M, Wang C, Stanczyk F, Diamandis EP: Prostate specific antigen in female serum, a potential new marker of androgen excess. J Clin Endocrinol Metab 1997;82:777-780.
43. Tsuyuki D, Grass L, Diamandis EP: Frequent detection of mutations in the 5' flanking region of the prostate specific antigen gene in female breast cancer. Eur J Cancer, in press.